Current Alzheimer Research

Editor-in-Chief:

Debomoy K. Lahiri  
Department of Psychiatry, Indiana University School of Medicine
Neuroscience Research Center
Indianapolis, IN 46202
USA

Back

Ahead of Print Article(s)

Estimating Alzheimer’s Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia

Volume:15
Matthew Davis, Thomas O`Connell, Scott Johnson, Stephanie Cline*, Elizabeth Merikle, Ferenc Martenyi and Kit N. Simpson

Vascular Risk Factors, Vascular Diseases, and Imaging Findings in a Hospital- based Cohort of Mild Cognitive Impairment Types

Volume:15
Cecilia Camarda*, Carmela Pipia, Delia Azzarello, Iacopo Battaglini, Giovanni Romeo, Marcello Chiodi and Rosolino Camarda

Tolfenamic Acid: A Modifier of the Tau Protein and its Role in Cognition and Tauopathy

Volume:15
J K Chang , A Leso , G M Subaiea, A Lahouel, A Masoud, F Mushtaq, R Deeb , A Eid, M Dash , S W Bihaqi and N H Zawia *

AβPP-induced UPR Transcriptomic Signature of Glial Cells to Oxidative Stress as an Adaptive Mechanism to Preserve Cell Function and Survival

Volume:15
Naima Chalour*, Agathe Maoui*, Patrice Rat, France Massicot, Melody Dutot, Anne-Marie Faussat, Estelle Devevre, Astrid Limb, Jean-Michel Warnet, Jacques Treton, Virginie Dinet and Frederic Mascarelli

Vascular Risk Factors and White Matter Hyperintensities as Predictors of Progression to Dementia in Patients with Mild Cognitive Impairment

Volume:15
Raul Romero Sevilla*, Ignacio Casado Naranjo, Juan Carlos Portilla Cuenca, Beatriz Duque de San Juan, Jose Manuel Fuentes Rodriguez and Fidel Lopez Espuela

(-)-Phenserine and Inhibiting Pre-Programmed Cell Death: In Pursuit of a Novel Intervention for Alzheimer’s Disease

Volume:15
Robert E. Becker*, Nigel H. Greig, Debomoy K. Lahiri, Joseph Bledsoe, Sarah Majercik, Clive Ballard, Dag Aarsland, Lon S. Schneider, Douglas Flanagan, Ramprakash Govindarajan, Mary Sano, Luigi Ferrucci and Dimitrios Kapogiannis

Relevance of Follow-Up in Patients with Core Clinical Criteria for Alzheimer Disease and Normal CSF Biomarkers

Volume:15
Olivier Vercruysse, Claire Paquet, Audrey Gabelle, Xavier Delbeuck, Frederic Blanc, David Wallon, Julien Dumurgier, Eloi Magnin, Olivier Martinaud, Barbara Jung, Olivier Bousiges, Sylvain Lehmann, Constance Delaby, Muriel Quillard-Murain, Katell Peoc’h, Jean-Louis Laplanche, Elodie Bouaziz-Amar, Didier Hannequin, Bernard Sablonniere, Luc Buee, Jacques Hugon, Susanna Schraen, Florence Pasquier and Stephanie Bombois*

Bromelain Degrades Aβ1-42 Monomers and Soluble Aggregates: An In Vitro Study in Cerebrospinal Fluid of Alzheimer’s Disease Patients

Volume:15
Giulia Maria Sancesario*, Marzia Nuccetelli, Andrea Cerri, Joshua Zegeer, Cinzia Severini, Maria Teresa Ciotti, Massimo Pieri, Alessandro Martorana, Carlo Caltagirone, Robert Nistico and Sergio Bernardini

Characteristics of Insulin-degrading Enzyme in Alzheimer's Disease: A Meta-Analysis

Volume:15
Huifeng Zhang, Dan Liu, Huanhuan Huang, Yujia Zhao and Hui Zhou*

Amyloid-β Inhibits PDGFβ Receptor Activation and Prevents PDGF-BBInduced Neuroprotection

Volume:15
Hui Liu*, Golam T. Saffi*, Maryam S. Vasefi, Youngjik Choi, Jeff S. Kruk, Nawaz Ahmed, Nyasha Gondora, John Mielke, Zoya Leonenko and Michael A. Beazely*

Compensatory Shift of Subcallosal Area and Paraterminal Gyrus White Matter Parameters on DTI in Patients with Alzheimer Disease

Volume:15
Barbora Kuchtova, Zdenek Wurst, Jana Mrzílkova, Ibrahim Ibrahim, Jaroslav Tintera, Ales Bartos, Vladimir Musil, Karel Kieslich and Petr Zach*

Autoimmunity and Frontotemporal Dementia

Volume:15
Antonella Alberici*, Viviana Cristillo, Stefano Gazzina, Alberto Benussi, Alessandro Padovani and Barbara Borroni

Potential Application of Centrifuges to Protect the CNS in Space and on Earth

Volume:15
Yoshiki Takamatsu, Gilbert Ho, Yuki Shimizu, Shuei Sugama, Takato Takenouchi, Masaaki Waragai, Jianshe Wei and Makoto Hashimoto*

Is it All Said for NSAIDs in Alzheimer’s Disease? Role of Mitochondrial Calcium Uptake

Volume:15
Sara Sanz-Blasco, Maria Calvo-Rodríguez, Erica Caballero, Monica Garcia-Durillo, Lucía Nunez and Carlos Villalobos*

Vitamin D Increases Aβ140 Plasma Levels and Protects Lymphocytes from Oxidative Death in Mild Cognitive Impairment Patients

Volume:15
Carol D San Martín, Mauricio Henriquez, Carlos Chacon, Daniela P Ponce, Felipe Salech, Nicole Rogers and María Isabel Behrens

An Inflammation-related Nutrient Pattern is Associated with Both Brain and Cognitive Measures in a Multiethnic Elderly Population

Volume:15
Yian Gu*, Jennifer J. Manly, Richard P. Mayeux and Adam M. Brickman

Cholinesterase Inhibitor 6-Chlorotacrine - In Vivo Toxicological Profile and Behavioural Effects

Volume:15
Jan Misik*, Eugenie Nepovimova, Jaroslav Pejchal, Jiri Kassa, Jan Korabecny and Ondrej Soukup

Up-regulation of DMN Connectivity in Mild Cognitive Impairment Via Network-based Cognitive Training

Volume:15
Matteo De Marco, Francesca Meneghello, Cristina Pilosio, Jessica Rigon and Annalena Venneri*

Phenolic Acids Exert Anticholinesterase and Cognition-Improving Effects

Volume:14
Dominik Szwajgier, Ewa Baranowska-Wojcik and Kamila Borowiec*

Catechol-O-methyltransferase, Cognition and Alzheimer’s Disease

Volume:15
Matea Nikolac Perkovic, Dubravka Svob Strac, Lucija Tudor, Marcela Konjevod, Gordana Nedic Erjavec and Nela Pivac*

Effects of Molecular Hydrogen Assessed by an Animal Model and a Randomized Clinical Study on Mild Cognitive Impairment

Volume:14
Kiyomi Nishimaki, Takashi Asada*, Ikuroh Ohsawa, Etsuko Nakajima, Chiaki Ikejima, Takashi Yokota, Naomi Kamimura and Shigeo Ohta

Erythrocyte Associated Amyloid-β as Potential Biomarker to Diagnose Dementia

Volume:14
Michele Lauriola*, Giulia Paroni, Filomena Ciccone, Grazia D`Onofrio, Leandro Cascavilla, Francesco Paris, Carolina Gravina, Maria Urbano, Davide Seripa and Antonio Greco

The Correlations between Postmortem Brain Pathologies and Cognitive Dysfunction in Aging and Alzheimer’s Disease

Volume:14
Wen-Ying Qiu, Qian Yang, Wanying Zhang, Naili Wang, Di Zhang, Yue Huang* and Chao Ma*

Cognitive Training in Patients with Alzheimer’s Disease: Findings of a 12- month Randomized Controlled Trial

Volume:14
Alessandro Trebbastoni*, Letizia Imbriano, Livia Podda, Lidia Rendace, Maria Luisa Sacchetti, Alessandra Campanelli, Fabrizia D`Antonio and Carlo de Lena

A Biomarker Combining Imaging and Neuropsychological Assessment for Tracking Early Alzheimer’s Disease in Clinical Trials

Volume:14
Nishant Verma*, S. Natasha Beretvas, Belen Pascual, Joseph C. Masdeu, Mia K. Markey and The Alzheimer`s Disease Neuroimaging Initiative

Reduced Serotonin Transporter Levels and Inflammation in the Midbrain Raphe of 12 Month Old APPswe/PSEN1dE9 Mice

Volume:14
Athanasios Metaxas*, Ramanan Vaitheeswaran, Katrine T. Jensen, Camilla Thygesen, Laura Ilkjaer, Sultan Darvesh and Bente Finsen

Quality of Life in Dementia Sufferers: The Role of Diet and Exercise

Volume:14
Pasquale Ricci, Francesco Massoni*, Lidia Ricci, Emanuela Onofri, Giuseppe Donato and Serafino Ricci

Pharmacogenetics of Angiotensin-Converting Enzyme Inhibitors in Patients with Alzheimer’s Disease Dementia

Volume:14
Fabricio Ferreira de Oliveira*, Elizabeth Suchi Chen, Marilia Cardoso Smith and Paulo Henrique Ferreira Bertolucci

Longitudinal Neuropsychological Outcome in Taiwanese Alzheimer's Disease Patients Treated with Medication

Volume:14
Yuan-Han Yang, Meng-Ni Wu, Ping-Song Chou, Hui-Chen Su, Sheng-Hsiang Lin and Pi-Shan Sung*

Modulation of Inflammation as a Way of Delaying Alzheimer’s Disease Progression: The Diet’s Role

Volume:14
R Businaro, M Corsi, R Asprino, C Di Lorenzo, D Laskin, R M Corbo, S Ricci and A Pinto

Frontotemporal Lobar Degeneration. Review and Update for Clinical Neurologists

Volume:14
Isabel Hernández*, Maria-Victoria Fernández, Lluis Tàrraga, Mercè Boada and Agustín Ruiz

Lipid Biomarkers in Alzheimer’s Disease

Volume:14
Amira Zarrouk, Meryam Debbabi, Maryem Bezine, El Mostafa Karym, Asmaa Badreddine, Olivier Rouaud, Thibault Moreau, Mustapha Cherkaoui-Malki, Mohamed El Ayeb, Boubker Nasser, Mohamed Hammami and Gérard Lizard*

Targeting PPARalpha in Alzheimer's Disease

Volume:14
Barbara D`Orio*, Anna Fracassi*, Maria Paola Cerù and Sandra Moreno

PPARs in Neurodegenerative and Neuroinflammatory Pathways

Volume:14
E Benedetti, L Cristiano , A Antonosante, M d’Angelo , B D’Angelo, S Selli, V Castelli, R Ippoliti, A Giordano and A Cimini *

The Involvement of Post-Translational Modifications in Alzheimer’s Disease

Volume:14
Serena Marcelli*, Massimo Corbo, Filomena Iannuzzi, Lucia Negri, Fabio Blandini, Robert Nisticò and Marco Feligioni

Emerging Biomarkers in Alzheimer’s Disease (Recent Update)

Volume:14
Sushil Sharma and Walter Lipincott

Treponema, Iron and Neurodegeneration

Volume:13
A. Jolivet-Gougeon and M. Bonnaure Mallet